NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $208K of Nuvectis Pharma, Inc.
Bought$208,047
$16.99Price
12,245Shares
What NVCT did for a copier
- $1,000 copied at Fri, May 13 open, $18.08
- $670
- S&P 500, same days
- −3.6%
Measured over 30 trading days, to the Jun 28 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +65.0% against the S&P 500, and 8 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 12. Filed Fri, May 13, 4:30 AM ET, before the open. Returns use the May 13 open and the Jun 28 close. Not investment advice.